Pharsight

Drugs that contain Ferric Oxyhydroxide

1. Velphoro patents expiration

VELPHORO's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10933090 VIFOR FRESENIUS Pharmaceutical compositions
Nov, 2028

(4 years from now)

US10925897 VIFOR FRESENIUS Pharmaceutical compositions
Nov, 2028

(4 years from now)

US11013761 VIFOR FRESENIUS Pharmaceutical compositions
Nov, 2028

(4 years from now)

US10695367 VIFOR FRESENIUS Pharmaceutical compositions
Nov, 2028

(4 years from now)

US11013762 VIFOR FRESENIUS Pharmaceutical compositions
Nov, 2028

(4 years from now)

US10925896 VIFOR FRESENIUS Pharmaceutical compositions
Nov, 2028

(4 years from now)

US10682376 VIFOR FRESENIUS Pharmaceutical compositions
Nov, 2028

(4 years from now)

US10925896

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions
May, 2029

(5 years from now)

US10933090

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions
May, 2029

(5 years from now)

US10695367

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions
May, 2029

(5 years from now)

US11013761

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions
May, 2029

(5 years from now)

US11013762

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions
May, 2029

(5 years from now)

US10925897

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions
May, 2029

(5 years from now)

US10682376

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions
May, 2029

(5 years from now)

US9561251 VIFOR FRESENIUS Pharmaceutical compositions
Jan, 2030

(5 years from now)

US9561251

(Pediatric)

VIFOR FRESENIUS Pharmaceutical compositions
Jul, 2030

(6 years from now)

US11446252 VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles
Nov, 2034

(10 years from now)

US11234938 VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles
Nov, 2034

(10 years from now)

US10624855 VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles
Nov, 2034

(10 years from now)

US10624855

(Pediatric)

VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles
May, 2035

(11 years from now)

US11234938

(Pediatric)

VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles
May, 2035

(11 years from now)

US11446252

(Pediatric)

VIFOR FRESENIUS Pharmaceutical composition, comprising phosphate binder particles
May, 2035

(11 years from now)

Market Authorisation Date: 27 November, 2013

Treatment: Control of phosphorous levels in patients

Dosage: TABLET, CHEWABLE;ORAL

More Information on Dosage

VELPHORO family patents

Family Patents